Skip to Content

Tsumura & Co TSMRF

Morningstar Rating
$26.76 +0.90 (3.48%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TSMRF is trading at a 289% premium.
Price
$26.82
Fair Value
$71.25
Uncertainty
High
1-Star Price
$37.53
5-Star Price
$89.73
Economic Moat
Ctnj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSMRF is a good fit for your portfolio.

Trading Information

Previous Close Price
$25.86
Day Range
$24.5026.76
52-Week Range
$18.1026.76
Bid/Ask
$23.28 / $27.38
Market Cap
$2.03 Bil
Volume/Avg
2,140 / 942

Key Statistics

Price/Earnings (Normalized)
17.44
Price/Sales
1.95
Dividend Yield (Trailing)
2.05%
Dividend Yield (Forward)
3.21%
Total Yield
2.52%

Company Profile

Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
4,882

Comparables

Valuation

Metric
TSMRF
4554
4577
Price/Earnings (Normalized)
17.4413.5311.26
Price/Book Value
1.140.860.64
Price/Sales
1.950.880.73
Price/Cash Flow
12.025.315.41
Price/Earnings
TSMRF
4554
4577

Financial Strength

Metric
TSMRF
4554
4577
Quick Ratio
2.120.550.82
Current Ratio
4.101.242.29
Interest Coverage
70.8958.74197.65
Quick Ratio
TSMRF
4554
4577

Profitability

Metric
TSMRF
4554
4577
Return on Assets (Normalized)
5.69%4.98%5.80%
Return on Equity (Normalized)
8.93%10.16%8.27%
Return on Invested Capital (Normalized)
6.28%6.17%7.32%
Return on Assets
TSMRF
4554
4577
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
WjptprptrGsgc$83.1 Bil
Merck KGaA ADR
MKKGY
HsqwsddhnZwbfgy$73.3 Bil
Haleon PLC ADR
HLN
VbyyxgndqBvbh$39.7 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
VdxpcznSjryx$19.0 Bil
Viatris Inc
VTRS
RtpnfqvzjTnmgc$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
WpjxjwvhvVjvs$13.2 Bil
Catalent Inc
CTLT
TqwvgdlgCxrnq$10.5 Bil
Perrigo Co PLC
PRGO
KgqcphmhNsqj$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
JdqhmhvwpPsbqrk$3.6 Bil
Curaleaf Holdings Inc
CURLF
GxsnmggfvSctn$3.2 Bil

Sponsor Center